Anteris Technologies and v2vmedtech have reached concept lock on the first phase of the system aiming to address unmet needs and provide better outcomes for patients with mitral and tricuspid valve disease. The milestone is an important step as they advance VClip™ toward a first-in-human study.
Company Information
Company
Anteris Technologies
Location
860 Blue Gentian Rd
Toowong, Queensland, Australia
About
Anteris® Technologies is a global structural heart company dedicated to revolutionizing cardiac care. Our mission is to forge new frontiers in cardiac care by pioneering science-driven and measurable advancements to restore heart valve patients to healthy function. Transcatheter Aortic Valve Replacement (TAVR) technologies were originally designed for older, high-risk patients. Today, younger, more active patients need a better solution that will not just open and close but restore healthy heart function. We sought to restore healthy blood flow patterns by creating the world’s first biomimetic TAVR valve, DurAVR® THV. This cutting-edge valve, incorporating our proprietary ADAPT® anti-calcification technology, is designed to mimic the natural function of a healthy heart valve.
ToowongManufacturingBiotechnologyHealth CareMedicalMedical Devicemedical devices